Statins and the Risk of Breast, Lung, Colorectal, and Prostate Cancers
Apart from their lipid-lowering effects and cardiovascular (CV) benefits, the cancer protective properties of statins have attracted much attention in recent years. However, there has been inconsistent evidence on the anti-cancer effectiveness of statins, with few studies even reporting paradoxically increased cancer incidence in statin users. Due to the well-established CV benefits of statin therapy in a large proportion of adults, both in primary and secondary CV prevention, any such potential harm on cancer incidence carries significant implications.
Source: Journal of Clinical Lipidology - Category: Lipidology Authors: Mounica Vorla, Pawan Daga, Muhammad Umer, Mathew Shotwell, Dinesh K Kalra Tags: Other Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cholesterol | Colorectal Cancer | Heart | Lipidology | Prostate Cancer | Statin Therapy | Study